• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A 型和 B 型爱泼斯坦-巴尔病毒自发进入裂解周期的能力有所不同。

A-type and B-type Epstein-Barr virus differ in their ability to spontaneously enter the lytic cycle.

作者信息

Buck M, Cross S, Krauer K, Kienzle N, Sculley T B

出版信息

J Gen Virol. 1999 Feb;80 ( Pt 2):441-445. doi: 10.1099/0022-1317-80-2-441.

DOI:10.1099/0022-1317-80-2-441
PMID:10073706
Abstract

In this study replication of A-type and B-type Epstein-Barr virus (EBV) strains has been assessed. A-type and B-type type lymphoblastoid cell lines (LCLs) were established by infecting B lymphocytes, isolated from five EBV-seropositive donors, with different A-type and B-type virus isolates. The presence of viral capsid antigens (VCA) in these LCLs was determined by immunofluoresence assay and by immunoblotting. All of the B-type EBV strains were capable of spontaneously generating virus regardless of the origin of the donor cells. In contrast the A-type strains, other than strain IARC-BL36, did not readily produce VCA in any of the different donor lymphocytes used. This study demonstrates another biological difference between the two virus types: their ability to spontaneously enter the lytic cycle.

摘要

在本研究中,对A 型和B 型爱泼斯坦-巴尔病毒(EBV)毒株的复制情况进行了评估。通过用不同的A 型和B 型病毒分离株感染从五名EBV 血清阳性供体中分离出的B 淋巴细胞,建立了A 型和B 型淋巴母细胞样细胞系(LCL)。通过免疫荧光测定法和免疫印迹法确定这些LCL 中病毒衣壳抗原(VCA)的存在。所有B 型EBV 毒株都能够自发产生病毒,而不论供体细胞的来源如何。相比之下,除IARC-BL36 毒株外,A 型毒株在所用的任何不同供体淋巴细胞中都不容易产生VCA。这项研究证明了这两种病毒类型之间的另一个生物学差异:它们自发进入裂解周期的能力。

相似文献

1
A-type and B-type Epstein-Barr virus differ in their ability to spontaneously enter the lytic cycle.A 型和 B 型爱泼斯坦-巴尔病毒自发进入裂解周期的能力有所不同。
J Gen Virol. 1999 Feb;80 ( Pt 2):441-445. doi: 10.1099/0022-1317-80-2-441.
2
Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.爱泼斯坦-巴尔病毒潜伏的调控与失调:对自身免疫性疾病发展的影响
Autoimmunity. 2008 May;41(4):298-328. doi: 10.1080/08916930802024772.
3
Characteristics of Epstein-Barr virus transformed B cell lines from patients with Alzheimer's disease and age-matched controls.来自阿尔茨海默病患者和年龄匹配对照的爱泼斯坦-巴尔病毒转化B细胞系的特征
Mech Ageing Dev. 1992 Mar 15;63(1):105-16. doi: 10.1016/0047-6374(92)90020-e.
4
Epstein-Barr virus-carrying B cells in the blood during acute infectious mononucleosis give rise to lymphoblastoid lines in vitro by release of transforming virus and by proliferation.在急性传染性单核细胞增多症期间,血液中携带爱泼斯坦-巴尔病毒的B细胞通过释放转化病毒和增殖在体外产生淋巴母细胞系。
Immunol Lett. 1990 Oct;26(1):59-65. doi: 10.1016/0165-2478(90)90176-q.
5
Establishment of EBV-Infected Lymphoblastoid Cell Lines.爱泼斯坦-巴尔病毒感染的淋巴母细胞系的建立。
Methods Mol Biol. 2017;1532:57-64. doi: 10.1007/978-1-4939-6655-4_3.
6
Establishment of spontaneously outgrowing lymphoblastoid cell lines with Cyclosporin A.用环孢菌素A建立自发生长的淋巴母细胞样细胞系。
Med Microbiol Immunol. 1983;172(2):87-99. doi: 10.1007/BF02124509.
7
T cells specific for different latent and lytic viral proteins efficiently control Epstein-Barr virus-transformed B cells.针对不同潜伏性和裂解性病毒蛋白的T细胞可有效控制爱泼斯坦-巴尔病毒转化的B细胞。
Cytotherapy. 2015 Sep;17(9):1280-91. doi: 10.1016/j.jcyt.2015.06.003.
8
STAT1 contributes to the maintenance of the latency III viral programme observed in Epstein-Barr virus-transformed B cells and their recognition by CD8+ T cells.
J Gen Virol. 2009 Sep;90(Pt 9):2239-50. doi: 10.1099/vir.0.011627-0. Epub 2009 May 13.
9
Differential cellular susceptibility to Epstein-Barr virus infection in a patient with X-linked lymphoproliferative disease.一名患有X连锁淋巴增生性疾病患者的细胞对爱泼斯坦-巴尔病毒感染的易感性差异
J Med Virol. 1990 Sep;32(1):47-52. doi: 10.1002/jmv.1890320108.
10
Epstein-Barr virus recombinants from BC-1 and BC-2 can immortalize human primary B lymphocytes with different levels of efficiency and in the absence of coinfection by Kaposi's sarcoma-associated herpesvirus.来自BC-1和BC-2的爱泼斯坦-巴尔病毒重组体能够使人类原代B淋巴细胞永生化,效率各异,且无需卡波西肉瘤相关疱疹病毒的共感染。
J Virol. 2000 Jan;74(2):735-43. doi: 10.1128/jvi.74.2.735-743.2000.

引用本文的文献

1
Exploring the Genetic Diversity of Epstein-Barr Virus among Patients with Gastric Cancer in Southern Chile.探讨智利南部胃癌患者中 EB 病毒的遗传多样性。
Int J Mol Sci. 2023 Jul 10;24(14):11276. doi: 10.3390/ijms241411276.
2
Identification and Cloning of a New Western Epstein-Barr Virus Strain That Efficiently Replicates in Primary B Cells.鉴定和克隆一种新型西氏爱泼斯坦-巴尔病毒株,该病毒株能在原代 B 细胞中高效复制。
J Virol. 2020 May 4;94(10). doi: 10.1128/JVI.01918-19.
3
Molecular pathogenesis of B-cell posttransplant lymphoproliferative disorder: what do we know so far?
B细胞移植后淋巴细胞增殖性疾病的分子发病机制:我们目前了解多少?
Clin Dev Immunol. 2013;2013:150835. doi: 10.1155/2013/150835. Epub 2013 Apr 14.
4
Progress and problems in understanding and managing primary Epstein-Barr virus infections.原发性 EBV 感染的理解和管理方面的进展和问题。
Clin Microbiol Rev. 2011 Jan;24(1):193-209. doi: 10.1128/CMR.00044-10.
5
Characterization of variants in the promoter of BZLF1 gene of EBV in nonmalignant EBV-associated diseases in Chinese children.中国儿童非恶性 EBV 相关疾病中 EBV BZLF1 基因启动子变异的特征。
Virol J. 2010 May 10;7:92. doi: 10.1186/1743-422X-7-92.
6
An HLA-A2-restricted T-cell epitope mapped to the BNLF2a immune evasion protein of Epstein-Barr virus that inhibits TAP.一个与HLA - A2相关的T细胞表位,定位于爱泼斯坦 - 巴尔病毒的BNLF2a免疫逃逸蛋白,该蛋白可抑制抗原加工相关转运体。
J Virol. 2009 Mar;83(6):2783-8. doi: 10.1128/JVI.01724-08. Epub 2009 Jan 7.
7
Correlation between infections with different genotypes of human cytomegalovirus and Epstein-Barr virus in subgingival samples and periodontal status of patients.龈下样本中不同基因型人巨细胞病毒和爱泼斯坦-巴尔病毒感染与患者牙周状况的相关性。
J Clin Microbiol. 2007 Nov;45(11):3665-70. doi: 10.1128/JCM.00374-07. Epub 2007 Sep 5.
8
Infection frequency of Epstein-Barr virus in subgingival samples from patients with different periodontal status and its correlation with clinical parameters.不同牙周状态患者龈下样本中EB病毒的感染频率及其与临床参数的相关性
J Zhejiang Univ Sci B. 2006 Nov;7(11):876-83. doi: 10.1631/jzus.2006.B0876.